US Patent 11034668 Compounds for the treatment of HIV
Patent 11034668 was granted and assigned to Gilead Sciences on June, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11034668 Compounds for the treatment of HIV
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.